BIOMAT Database Logo BIOMAT Database Logo

Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. 1995

S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Department of Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway 08854-5635, USA.

Ehlers-Danlos syndrome type IV (EDS IV) is an autosomal dominant disorder characterized by fragile skin, blood vessels, and internal organs and associated with decreased production, secretion, or thermal stability of type III procollagen. Mutations in the gene for type III procollagen have been identified in patients exhibiting decreased secretion or thermal stability of the protein, but no defect has been elucidated to explain the decreased production of type III procollagen in some patients with EDS IV. We report on a patient with a moderate case of EDS IV who produced decreased amounts of type III procollagen despite normal levels of translatable type III procollagen mRNA. S1 nuclease analysis of the type III procollagen mRNA indicated a defect in the region encoding exon 27. Sequence analysis of cDNA clones and genomic fragments generated by polymerase chain reaction amplification revealed that sequences encoded by exon 27 were absent from 3 out of 5 cDNA clones and that a G at the +5 position of the splice donor site in intron 27 was changed to an A in one allele of the patient's type III procollagen gene. Using a cDNA-genomic DNA hybrid probe in S1 nuclease analysis, fragments consistent with mRNA species containing and lacking exon 27 were detected in a 1:1 ratio. Pulse label and chase experiments in the presence or absence of brefeldin A indicated that most of the type III procollagen molecules synthesized by the patient's fibroblasts were not secreted into the medium but were degraded in the endoplasmic reticulum-Golgi compartment by a nonlysosomal mechanism.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004535 Ehlers-Danlos Syndrome A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability. Cutis Elastica,Ehlers Danlos Disease,Ehlers-Danlos Disease,Danlos Disease, Ehlers,Disease, Ehlers Danlos,Disease, Ehlers-Danlos,Ehlers Danlos Syndrome,Syndrome, Ehlers-Danlos
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012326 RNA Splicing The ultimate exclusion of nonsense sequences or intervening sequences (introns) before the final RNA transcript is sent to the cytoplasm. RNA, Messenger, Splicing,Splicing, RNA,RNA Splicings,Splicings, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
November 1984, American journal of medical genetics,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV.
May 1989, Human genetics,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
August 1990, Laboratory investigation; a journal of technical methods and pathology,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Temperature sensitivity of aberrant RNA splicing with a mutation in the G+5 position of intron 37 of the gene for type III procollagen from a patient with Ehlers-Danlos syndrome type IV.
January 1993, Human mutation,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.
September 1986, Human genetics,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
A nonsense codon of exon 14 reduces lysyl hydroxylase mRNA and leads to aberrant RNA splicing in a patient with Ehlers-Danlos syndrome type VI.
February 2000, Mutation research,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Multiexon deletion in the procollagen III gene is associated with mild Ehlers-Danlos syndrome type IV.
March 1991, The Journal of biological chemistry,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Substitution of valine for glycine 793 in type III procollagen in Ehlers-Danlos syndrome type IV.
January 1995, Human mutation,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
November 2001, American journal of human genetics,
S Thakker-Varia, and D W Anderson, and H Kuivaniemi, and G Tromp, and H G Shin, and M van der Rest, and F H Glorieux, and L Ala-Kokko, and C A Stolle
Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
April 1988, European journal of clinical investigation,
Copied contents to your clipboard!